Stéphane Bancel, AP Images
Covid-19 roundup: Moderna says vaccine produces 'strong' response in 5- to 11-year-olds; Aspen Pharmacare plans to up vaccine production in South Africa — report
After seeing a “robust” immune response in 6- to 11-year-olds dosed with its Covid-19 vaccine, Moderna says it’s headed to the FDA.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
